RDS has raised €14m ($16.4m) to accelerate the European market roll-out of MultiSense, a remote patient monitoring (RPM) ...

A research team spearheaded by Harvard Medical School (HMS) in the US has created an AI tool, dubbed Pathology Image ...

Health Canada has granted authorisation for Abbott’s Esprit BTK Everolimus Eluting Resorbable Scaffold System.

A new report by EY has revealed that despite tariff uncertainty, the medtech industry has recorded its seventh successive ...

Accuray has introduced a new all-in-one adaptive radiotherapy solution, Accuray Stellar, tailored initially for the US market ...

Zimmer Biomet has secured approval from Japan's Pharmaceutical and Medical Devices Agency (PMDA) for iTaperloc Complete and ...

Diabetes software company Glooko has acquired Monarch Medical Technologies in a move that will help the company to expand its ...

South Korean company Lunit and Canada-based CellCarta have partnered to integrate digital pathology AI into clinical trials.

The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge ...

The US Food and Drug Administration (FDA) has chosen to axe its ‘Final Rule’ from May 2024, bringing to an end a long-running ...

The FDA has granted de novo classification to the Biolinq Shine wearable biosensor, which would be the first needle-free CGM ...

Radiotherapy technology developer Leo Cancer Care has raised $40m to further the commercial reach of its upright radiotherapy ...